Filtered By:
Specialty: Cardiology
Condition: Congestive Heart Failure

This page shows you your search results in order of date. This is page number 3.

Order by Relevance | Date

Total 580 results found since Jan 2013.

Safety and Efficacy of Rivaroxaban, Apixaban, and Dabigatran in Obese and Morbidly Obese Patients with Heart Failure and Atrial Fibrillation: A Real ‐World Analysis
ConclusionIn obese patients with congestive heart failure and atrial fibrillation or atrial flutter on DOACs, apixaban has the most favorable safety profile compared to rivaroxaban and dabigatran.This article is protected by copyright. All rights reserved
Source: Pacing and Clinical Electrophysiology : PACE - November 24, 2022 Category: Cardiology Authors: Yashasvi Chugh, Kashvi Gupta, Hanumanthu Balram Krishna, Renato Quispe Ayala, Ignacio Zepeda, Michael Grushko, Robert T Faillace Tags: ORIGINAL ARTICLE Source Type: research

Outcomes of Carotid Stenting in Patients with Fibromuscular Dysplasia
CONCLUSION: Carotid artery stenting for fibromuscular dysplasia is a feasible and safe procedure with favorable technical success, low neurological complications, and good clinical outcomes at 1-year follow-up.PMID:36400362 | DOI:10.1016/j.jvs.2022.10.040
Source: Atherosclerosis - November 18, 2022 Category: Cardiology Authors: Jesus Porras-Colon Carla K Scott Alejandro Pizano Anna Driessen Carlos H Timaran John G Modrall Shirling Tsai Melissa L Kirkwood Bala Ramanan Source Type: research

Application of computed tomographic angiography and echocardiography in predicting left atrial appendage thrombosis in patients with non-valvular atrial fibrillation
CONCLUSIONS: Both CTA and RT-3D-TEE had high predictive values for LAA thrombosis in atrial fibrillation patients.PMID:36383152 | DOI:10.5830/CVJA-2022-052
Source: Cardiovascular Journal of Africa - November 16, 2022 Category: Cardiology Authors: Xiaodan Wu Fan Sun Shoucheng Ma Zhichen Wang Shenghai Xu Source Type: research

Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events
ConclusionsIn patients who receive clopidogrel after PCI, concomitant use of PPI seems to increase the risk of major cardiovascular events.
Source: Cardiovascular Drugs and Therapy - November 11, 2022 Category: Cardiology Source Type: research

Photoplethysmography-Based Smart Devices for Detection of Atrial Fibrillation
Tex Heart Inst J. 2022 Sep 1;49(5):e217564. doi: 10.14503/THIJ-21-7564.ABSTRACTAtrial fibrillation is the most commonly experienced type of cardiac arrhythmia and is the most associated with substantial clinical occurrences and expenses. This arrhythmia often occurs in its "silent" asymptomatic form, revealed only after complications such as a stroke or congestive heart failure have transpired. New smart devices confer effective advantages in the detection of this heart arrhythmia, of which photoplethysmography-based smart devices have shown great potential, according to previous research. However, the solution becomes a p...
Source: Texas Heart Institute Journal - October 27, 2022 Category: Cardiology Authors: Adna Sijer čić Elnur Tahirovi ć Source Type: research

Percutaneous revascularization for atherosclerotic renal artery stenosis: a meta-analysis
CONCLUSIONS: Medication therapy alone is as effective and safe as PR.PMID:36263548 | DOI:10.26355/eurrev_202210_29884
Source: Atherosclerosis - October 20, 2022 Category: Cardiology Authors: Y Li W-H Cui J Wang X Chen C Zhang L-Z Zhu S-J Cui C-J Bian T Luo Source Type: research

RNA modifications in aging-associated cardiovascular diseases
Aging (Albany NY). 2022 Sep 29;14(undefined). doi: 10.18632/aging.204311. Online ahead of print.ABSTRACTCardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide that bears an enormous healthcare burden and aging is a major contributing factor to CVDs. Functional gene expression network during aging is regulated by mRNAs transcriptionally and by non-coding RNAs epi-transcriptionally. RNA modifications alter the stability and function of both mRNAs and non-coding RNAs and are involved in differentiation, development, and diseases. Here we review major chemical RNA modifications on mRNAs and non-co...
Source: Atherosclerosis - September 30, 2022 Category: Cardiology Authors: Xinyu Yang Priyanka Gokulnath H Immo Lehmann Zhitao Hou Sun Yang Liangzhen You Guoxia Zhang Yanwei Xing Ji Lei Guoping Li Shuwen Guo Hongcai Shang Source Type: research